PHAXIAM Therapeutics S.A. (EPA:PHXM)
0.2010
-0.0050 (-2.43%)
May 27, 2025, 4:46 PM CET
PHAXIAM Therapeutics Statistics
Total Valuation
EPA:PHXM has a market cap or net worth of EUR 2.01 million. The enterprise value is 4.80 million.
Market Cap | 2.01M |
Enterprise Value | 4.80M |
Important Dates
The next estimated earnings date is Wednesday, September 24, 2025.
Earnings Date | Sep 24, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
EPA:PHXM has 10.05 million shares outstanding.
Current Share Class | 10.05M |
Shares Outstanding | 10.05M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.16% |
Owned by Institutions (%) | 38.11% |
Float | 10.03M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.94 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.22 |
EV / Sales | 2.24 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 31,485 |
Profits Per Employee | -322,382 |
Employee Count | 68 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.85% in the last 52 weeks. The beta is 1.83, so EPA:PHXM's price volatility has been higher than the market average.
Beta (5Y) | 1.83 |
52-Week Price Change | -92.85% |
50-Day Moving Average | 0.52 |
200-Day Moving Average | 1.44 |
Relative Strength Index (RSI) | 35.18 |
Average Volume (20 Days) | 135,911 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EPA:PHXM had revenue of EUR 2.14 million and -21.92 million in losses.
Revenue | 2.14M |
Gross Profit | 2.14M |
Operating Income | -18.11M |
Pretax Income | -21.90M |
Net Income | -21.92M |
EBITDA | -18.90M |
EBIT | -18.11M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | n/a |
Book Value Per Share | n/a |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 100.00% |
Operating Margin | -845.73% |
Pretax Margin | -1,022.98% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
EPA:PHXM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -1,090.60% |
FCF Yield | n/a |
Stock Splits
The last stock split was on September 18, 2023. It was a reverse split with a ratio of 0.1.
Last Split Date | Sep 18, 2023 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |